A detailed history of Nea Management Company, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 3,969,834 shares of AUPH stock, worth $35.2 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
3,969,834
Previous 3,969,834 -0.0%
Holding current value
$35.2 Million
Previous $22.7 Million 28.37%
% of portfolio
2.22%
Previous 2.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$10.05 - $22.48 $9.05 Million - $20.2 Million
900,000 Added 29.32%
3,969,834 $49.1 Million
Q4 2021

Feb 14, 2022

SELL
$17.78 - $33.08 $37.4 Million - $69.6 Million
-2,102,849 Reduced 40.65%
3,069,834 $70.2 Million
Q1 2019

May 08, 2019

BUY
$6.06 - $7.64 $2.21 Million - $2.78 Million
364,200 Added 7.57%
5,172,683 $33.6 Million
Q3 2017

Nov 03, 2017

BUY
$5.71 - $6.9 $27.5 Million - $33.2 Million
4,808,483
4,808,483 $30.1 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.26B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.